This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fudan University. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Huaqing Li: Innovator in Hepatitis B Vaccine Enhancement
Introduction
Huaqing Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of vaccine development, particularly in enhancing the efficacy of the hepatitis B virus vaccine. His innovative work has the potential to improve public health outcomes for individuals affected by this virus.
Latest Patents
Huaqing Li holds a patent for his invention titled "Enhancing of hepatitis B virus vaccine and its gene." This invention relates to a hepatitis B vaccine enhancing protein, its gene, and the gene engineering method for expressing this protein. The cDNA of this protein is screened from a human liver cDNA library, sequenced, and then cloned into prokaryotic or eukaryotic cells for protein expression. The resulting protein, when used in conjunction with the hepatitis B vaccine, significantly increases the vaccine's effectiveness, boosts the immune response of hepatitis B virus carriers, and elevates antibody titers. This protein serves as an adjuvant to the hepatitis B vaccine.
Career Highlights
Huaqing Li is affiliated with Fudan University, where he conducts research and develops innovative solutions in the field of virology and immunology. His work has garnered attention for its potential impact on vaccine development and public health.
Collaborations
Huaqing Li collaborates with notable colleagues, including Naishuo Zhu and Min Yang, who contribute to his research efforts and advancements in vaccine technology.
Conclusion
Huaqing Li's contributions to the enhancement of the hepatitis B vaccine exemplify the importance of innovation in the medical field. His work not only advances scientific knowledge but also holds promise for improving health outcomes for individuals affected by hepatitis B.